Article info
PDFClinical science
Corneal Transplant Follow-up Study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplasty
- Correspondence to Professor W John Armitage, Translational Health Sciences, University of Bristol, Bristol Eye Hospital, Bristol BS1 2LX, UK; w.j.armitage{at}bristol.ac.uk
Citation
Corneal Transplant Follow-up Study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplasty
Publication history
- Received July 20, 2020
- Revised November 2, 2020
- Accepted November 14, 2020
- First published December 2, 2020.
Online issue publication
May 11, 2023
Article Versions
- Previous version (11 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.